↓ Skip to main content
NCW
  1. Health/

Fatty Liver Is the First Domino

·1130 words·6 mins· loading · loading · ·
Metabolic Health Biomarkers Nutrition
Neo W.
Author
Neo W.
Writing about things that intrigue me.
Table of Contents

Fatty Liver Is the First Domino
#

Roughly three in ten adults worldwide have fat in their liver. Most don’t know. It produces no pain, and the early symptoms get filed under stress, age, or a bad night’s sleep — while the organ that regulates your blood sugar quietly stops doing it properly.

The liver is a metabolic organ before it is a detox organ
#

Popular health writing treats the liver as a filter. That framing is why people miss what’s happening to it. The liver’s more consequential job is regulating fuel: storing glucose, releasing it when you need it, packaging fats, producing bile. When fat accumulates inside liver cells, that regulation degrades first — long before anything shows up as liver disease.

The condition now carries the name metabolic dysfunction-associated steatotic liver disease (MASLD), replacing the older NAFLD label. The rename matters because it puts the emphasis where the evidence points: this is a metabolic problem that manifests in the liver, not a liver problem that happens to affect metabolism. A 2024 meta-analysis pooling 78 million people across 38 countries put global prevalence at 30.2%, with men at 36.6% and women at 25.5%.

That prevalence is the reason the early signals are worth knowing. They are common, vague, and almost perfectly designed to be dismissed.

The signals are all downstream of one thing
#

The scattered symptoms people notice — the fatigue, the sugar cravings, the widening waist, the heaviness after a rich meal — aren’t a list of unrelated complaints. They’re what hepatic insulin resistance feels like from the inside.

Fatigue that sleep doesn’t touch. Not ordinary tiredness — a persistent background flatness. A fat-loaded liver handles glucose erratically and generates low-grade inflammation, and the combination produces exhaustion that rest doesn’t resolve.

A waist that expands while the scale barely moves. Visceral fat and liver fat drive each other, and you don’t need to be overweight for it. Lean MASLD is real and accounts for an estimated 5–20% of cases globally, rising to roughly 45% in some Asian cohorts. The practical measure here is better than BMI: NICE guidance classifies a waist-to-height ratio of 0.4–0.49 as healthy, 0.5–0.59 as increased risk, and 0.6 or above as high risk. Keep your waist under half your height.

Blood sugar that drifts upward. A stressed liver keeps dumping glucose into the blood even when there’s already plenty there. Rising HbA1c, post-meal crashes, and sugar cravings are the visible edge of that. This is frequently where the road to type 2 diabetes actually begins.

Mildly raised liver enzymes. Slightly elevated ALT, AST, or GGT on routine bloods is one of the earliest biochemical signals, and it is routinely waved through as “borderline”. A single mildly abnormal result isn’t a diagnosis — but a pattern of them deserves follow-up rather than a shrug.

Dull pressure under the right ribs, or early fullness, or nausea after fatty meals. An enlarged liver stretches its fibrous capsule and can physically press on the stomach. Impaired bile production means dietary fat isn’t emulsified properly. These get attributed to bloating, IBS, or a pulled muscle far more often than to the organ sitting directly underneath.

No single one of these proves anything. Several together, in someone with a widening waist and creeping blood sugar, is a pattern worth investigating.

The genuinely good news is dose-dependent
#

Here’s what makes this worth acting on rather than worrying about: the liver regenerates, and the response to weight loss is measurable and graded.

The clearest evidence comes from Vilar-Gomez et al. (2015, Gastroenterology), which followed 293 patients with biopsy-confirmed disease through 52 weeks of lifestyle change and re-biopsied them. The results form a ladder:

  • ≥5% body weight lost — hepatic steatosis improves
  • ≥7% — steatohepatitis resolves in a substantial share of patients
  • ≥10% — fibrosis regresses

That last rung matters most, because fibrosis was long treated as the point of no return. It isn’t, at least not early. Note the honest limits though: 25% of the cohort achieved resolution of steatohepatitis and 19% had fibrosis regression — real, replicated, but not universal.

The interventions with the best evidence behind them are unglamorous: reduce ultra-processed food, cut alcohol, increase dietary fibre, and fix sleep. Fibre earns its place because it blunts the glucose and insulin excursions that keep the liver in fat-storage mode.

What the evidence doesn’t say
#

Two honest caveats. First, weight loss is the intervention with the strongest histological evidence, but sustaining it is where most people fail — the trial above achieved its results with structured support, not willpower alone. Second, the symptom list is genuinely non-specific. Fatigue and bloating have dozens of causes, and reading this article is not a reason to conclude you have liver disease. It’s a reason to get baseline bloods if several signals line up.

Summary
#

Fat in the liver is the earliest and most reversible stage of the metabolic decline that ends in type 2 diabetes and cardiovascular disease. It affects around 30% of adults globally, produces no pain, and announces itself only through symptoms that are easy to attribute to something else. The upside is that it responds to weight loss in a measured, dose-dependent way — 5% improves the fat, 7% resolves the inflammation, 10% can reverse early scarring.

What to actually do:

  1. Measure your waist and compare it to your height. Under half is the target. This catches the “normal BMI, fat liver” case that weight alone misses.
  2. Ask for baseline bloods — ALT, AST, GGT, fasting glucose or HbA1c, and a lipid panel — especially if you have several of the signals above.
  3. Don’t accept “borderline” as “fine” on repeated liver enzymes. Ask what the trend is and whether an ultrasound is warranted.
  4. Target the fibre, not just the calories. It flattens the insulin spikes that keep fat parked in the liver.
  5. Treat 5% as the first meaningful milestone, not 20%. The histology moves before the mirror does.

Sources & further reading
#

  • Riazi K. et al. / Younossi Z. et al., Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis of 78 million people across 38 countries (2024) — PubMed
  • Vilar-Gomez E. et al., Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis, Gastroenterology (2015) — PubMed
  • Global prevalence, metabolic characteristics and outcomes of lean-MAFLD: a systematic review and meta-analysis — PMC
  • The emerging phenotype of nonalcoholic fatty liver disease in lean individuals — PMC
  • NICE, Overweight and obesity management (NG246): identifying and assessing overweight, obesity and central adiposity — NICE
  • NICE, Keep the size of your waist to less than half of your height — NICE
  • AASLD, Steatotic liver disease: cutting through the fat — AASLD
  • Diet and lifestyle interventions in metabolic dysfunction-associated fatty liver disease: a comprehensive review — PMC

Related

Cook It, Cool It, Eat It Cold

·992 words·5 mins· loading · loading
Gut Health Metabolic Health Nutrition
Cook It, Cool It, Eat It Cold # In a four-month randomised trial, people with fatty liver disease taking resistant starch cut liver fat by 9.08% — and 5.89% of that persisted after adjusting for weight loss. You can manufacture the same compound at home by cooking potatoes or rice and putting them in the fridge. The two fats that actually matter # Not all body fat carries the same risk. Two kinds do most of the damage: visceral fat, packed around the organs, and liver fat. Both sit upstream of type 2 diabetes and cardiovascular disease, and both can be substantial in someone whose weight looks unremarkable.

Your Kidneys Whisper Before Anything Else Shouts

·1147 words·6 mins· loading · loading
Biomarkers Metabolic Health Cardiovascular Health
Your Kidneys Whisper Before Anything Else Shouts # You can lose half your kidney function and feel completely normal. The organ has so much spare capacity that it hides its own decline for years — which is exactly why the small, ignorable signals it does produce are worth more than they look. The kidney is a vascular organ, and that’s the point # Each kidney contains roughly a million microscopic filtering units, working continuously to clear waste, balance fluid and salts, and regulate blood pressure. What makes them a useful early-warning system isn’t the filtering — it’s what they’re built from.

Push-Up Capacity Is a Vital Sign

·1080 words·6 mins· loading · loading
Strength Training Metabolic Health Biomarkers
Push-Up Capacity Is a Vital Sign # Men who could do 40 or more push-ups had a 96% lower rate of cardiovascular events over the following decade than men who could manage 10 or fewer. The test cost nothing, took two minutes, and predicted risk better than a treadmill. The study, and what it actually showed # The finding comes from Yang et al. (2019, JAMA Network Open), a longitudinal cohort of male firefighters in Indiana followed for ten years. Participants were stratified by how many push-ups they could complete at baseline. Over the decade, 37 cardiovascular events were recorded — and all but one occurred in men who had managed 40 or fewer at the start.
← It's One System, Not Twelve Protocols The Boring Eight →
comments powered by Disqus